BioCentury

8:00 AM GMT, Nov 8, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Horizant gabapentin enacarbil regulatory update

FDA accepted for review a response from GlaxoSmithKline to a February complete response letter for Horizant gabapentin enacarbil (XP13512,

Read the full 196 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.